Patient Outcomes in Unattended and In- Lab Polysomnography
Primary Purpose
Sleep Apnea, Hypersomnia
Status
Suspended
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Attended Polysomnography in the Lab
Unattended Polysomnography in the Home
Sponsored by
About this trial
This is an interventional diagnostic trial for Sleep Apnea
Eligibility Criteria
Inclusion Criteria:
- referral for major concern of "snoring" or "apnea" or "hypersomnia" with additional minor concerns of "snoring", "apneas" "restless leg syndrome" or "insomnia"
- willing to undergo a sleep study
Exclusion Criteria:
- referrals where parasomnias, respiratory failure, narcolepsy listed as concerns
- comorbid congestive heart failure, ischemic heart disease, arrhythmia, stroke, chronic obstructive pulmonary disease/respiratory failure, patients with a BMI 50 kg/m2
- undergone a previous sleep study
Sites / Locations
- Sleep Disorders Centre
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Level 1 In Lab Polysomnography
Level 2 In Home Polysomnography
Arm Description
Outcomes
Primary Outcome Measures
Change in Functional Outcomes of Sleep Questionnaire
Total Score scale ranges from 5-20, with higher scores representing better functioning
Change in Epworth Sleepiness Scale
Scale ranges from 0-24, with higher scores representing more sleepiness
Continuous Positive Airway Pressure (CPAP) Adherence
Percent of nights with CPAP > 4 hours/night
Change in Calgary Sleep Apnea Quality of Life Index
Total score ranges from 1-7, with a greater score indicating a lower effect of OSA on quality of life
Rating of Physician Diagnostic Confidence
Likert scale rating performed by physicians to assess confidence in diagnosis from data provided by the two systems, scale from 1-5 with higher values reflecting greater confidence
Rating of Patient Satisfaction
Likert scale rating of patient satisfaction for their sleep study experience, ranges from 1-7 with higher values reflecting greater satisfaction
Cost between Level 1 and Level 2 tests based on equipment, facility, supply costs, and technician and physician service fees
Secondary Outcome Measures
Full Information
NCT ID
NCT05230394
First Posted
December 30, 2021
Last Updated
February 6, 2023
Sponsor
Cerebra Medical
Collaborators
University of Manitoba
1. Study Identification
Unique Protocol Identification Number
NCT05230394
Brief Title
Patient Outcomes in Unattended and In- Lab Polysomnography
Official Title
Randomized Control Trial to Compare Patient Outcomes Following Unattended Polysomnography Versus In-lab Polysomnography for Sleep Apnea and Comorbid Sleep Disorders
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Suspended
Why Stopped
Funding Issues
Study Start Date
August 2023 (Anticipated)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Cerebra Medical
Collaborators
University of Manitoba
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This randomized controlled study will directly evaluate whether unattended polysomnography (level 2 sleep study) in individuals referred for sleep apnea or hypersomnia, including those with comorbidities of insomnia and sleep-related movement disorders, provides similar patient outcomes when compared to level 1 sleep studies.
Detailed Description
Individuals referred to the Sleep Disorder Centre with a major complaint of snoring or, apneas or hypersomnia, with at least one additional minor concern of snoring, apneas, restless leg syndrome or insomnia, will be considered for entry into the study. Using a randomized controlled trial design, study participants will be randomly assigned to either the intervention group who will undergo a full unattended polysomnography (level 2 home sleep study) using the Prodigy portable wireless sleep monitor or in-lab polysomnography (level 1 sleep study). Other aspects of care including the clinical assessment will be equivalent between groups. A randomly assigned sleep specialist physician will make treatment recommendations to the patient based on the sleep study results and determine the need for a subsequent testing (including repeat sleep studies) as part of each patient encounter. Physicians participating in the study will receive an introduction to the Odds Ratio Product (ORP) and training on its diagnostic potential. Diagnostic confidence using a 5 point Likert scale from 10% (very unsure) to 90% (very confident) will be assessed after each sleep study review.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Apnea, Hypersomnia
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
194 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Level 1 In Lab Polysomnography
Arm Type
Experimental
Arm Title
Level 2 In Home Polysomnography
Arm Type
Experimental
Intervention Type
Diagnostic Test
Intervention Name(s)
Attended Polysomnography in the Lab
Intervention Description
Using standard Level 1 polysomnography
Intervention Type
Diagnostic Test
Intervention Name(s)
Unattended Polysomnography in the Home
Intervention Description
Using Cerebra's Prodigy system
Primary Outcome Measure Information:
Title
Change in Functional Outcomes of Sleep Questionnaire
Description
Total Score scale ranges from 5-20, with higher scores representing better functioning
Time Frame
4 months
Title
Change in Epworth Sleepiness Scale
Description
Scale ranges from 0-24, with higher scores representing more sleepiness
Time Frame
4 months
Title
Continuous Positive Airway Pressure (CPAP) Adherence
Description
Percent of nights with CPAP > 4 hours/night
Time Frame
4 months
Title
Change in Calgary Sleep Apnea Quality of Life Index
Description
Total score ranges from 1-7, with a greater score indicating a lower effect of OSA on quality of life
Time Frame
4 months
Title
Rating of Physician Diagnostic Confidence
Description
Likert scale rating performed by physicians to assess confidence in diagnosis from data provided by the two systems, scale from 1-5 with higher values reflecting greater confidence
Time Frame
within 4 weeks of sleep study, after patient assessment by physician
Title
Rating of Patient Satisfaction
Description
Likert scale rating of patient satisfaction for their sleep study experience, ranges from 1-7 with higher values reflecting greater satisfaction
Time Frame
Measured in morning following their sleep study
Title
Cost between Level 1 and Level 2 tests based on equipment, facility, supply costs, and technician and physician service fees
Time Frame
After study conclusion, an average of up to 1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
referral for major concern of "snoring" or "apnea" or "hypersomnia" with additional minor concerns of "snoring", "apneas" "restless leg syndrome" or "insomnia"
willing to undergo a sleep study
Exclusion Criteria:
referrals where parasomnias, respiratory failure, narcolepsy listed as concerns
comorbid congestive heart failure, ischemic heart disease, arrhythmia, stroke, chronic obstructive pulmonary disease/respiratory failure, patients with a BMI 50 kg/m2
undergone a previous sleep study
Facility Information:
Facility Name
Sleep Disorders Centre
City
Winnipeg
State/Province
Manitoba
ZIP/Postal Code
R3C 1A2
Country
Canada
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Patient Outcomes in Unattended and In- Lab Polysomnography
We'll reach out to this number within 24 hrs